Comparison of long-term survival between nivolumab plus ipilimumab and nivolumab plus ipilimumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study

JTO Clinical and Research Reports · Published 2026-07-01 · DOI 10.1016/j.jtocrr.2026.101048

Free full text

Authors (19)

Kiyohide Komuta, Kinnosuke Matsumoto, Motohiro Tamiya, Takayuki Shiroyama, Yuhei Kinehara, Akihiro Tamiya, Tomoki Kuge, Junji Uchida, Hidekazu Suzuki, Suguru Yamamoto, Satoshi Tobita, Toshie Niki, Satoshi Tetsumoto, Osamu Morimura, Akio Osa, Toshiyuki Minami, Kazumi Nishino, Yoshito Takeda, Atsushi Kumanogoh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Komuta, K., Matsumoto, K., Tamiya, M., et al. (2026). Comparison of long-term survival between nivolumab plus ipilimumab and nivolumab plus ipilimumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study. JTO Clinical and Research Reports. https://doi.org/10.1016/j.jtocrr.2026.101048

Related articles

• Tarlatamab in Relapsed Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: A Case with Comparative DLL3 Expression Analysis · JTO Clinical and Research Reports · 2026 · Same journal
• Lung Cancer Screening Recommendations in the Elderly: International Society for Geriatric Oncology (SIOG) Consensus Statement · JTO Clinical and Research Reports · 2026 · Same journal
• Concurrent Hypertrophic Osteoarthropathy and Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis in a Patient With NSCLC: A Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Lung Cancer Screening Eligible Population from 2000 to 2050 in Argentina. A simulation study brief report · JTO Clinical and Research Reports · 2026 · Same journal
• Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Safety and Efficacy of Bronchoscopic Pulsed Electric Field Ablation for Lung Cancer and Metastases · JTO Clinical and Research Reports · 2026 · Same journal
• Multi-Institutional Integration of Circulating miRNAs and Protein Tumor Markers for Early Lung Cancer Detection · JTO Clinical and Research Reports · 2026 · Same journal
• Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study · JTO Clinical and Research Reports · 2026 · Same journal
• Pembrolizumab Plus Chemotherapy for Metastatic Squamous Non‒Small-Cell Lung Cancer: Long-Term Follow-Up of the KEYNOTE-407 China Study · JTO Clinical and Research Reports · 2026 · Same journal